Ozempic®
Weight Loss Treatment
Semaglutide
From $1,299.99 with subscription
0.25/0.5 mgOne-time $1,399.99
Complete a short online consultation. A licensed U.S. provider reviews your answers and decides whether treatment is appropriate, and anything prescribed is filled by a licensed U.S. pharmacy and shipped to you, in temperature-controlled packaging when the medication needs refrigeration.
See treatment optionsPrescription treatments. A licensed U.S. provider reviews your answers and decides whether treatment is appropriate.

US Quick Health offers GLP-1 and GIP weight loss treatments prescribed online by licensed U.S. providers: Wegovy® and Ozempic® (semaglutide), Mounjaro® and Zepbound® (tirzepatide), plus oral options including Wegovy Tablets and Foundayo™, as well as compounded semaglutide and compounded tirzepatide. Compounded medications are not FDA-approved. Complete an online consultation, and if a provider approves treatment, a licensed U.S. pharmacy fills and ships your prescription.
Weight Loss Treatment
Semaglutide
From $1,299.99 with subscription
0.25/0.5 mgOne-time $1,399.99
Prescription tirzepatide · Medical evaluation required
From $1,439.99 with subscription
2.5 mgOne-time $1,539.99
Semaglutide · Weight Loss Treatment
From $1,742.99 with subscription
9 mg, 30 TabletsOne-time $1,842.99
Oral Weight Loss Treatment · Tablets
Orforglipron
From $1,042.99 with subscription
0.8 mg, 30 TabletsOne-time $1,142.99
Prices shown are starting prices. The price displayed for your selected treatment plan is the full price you pay for that plan. Available as a one-time purchase or subscription, if prescribed. Prescription treatment is only available if a licensed healthcare provider determines it is appropriate following an online evaluation. If you are not eligible for treatment, you may be eligible for a full refund under our Money-Back Guarantee. If prescribed, medication is dispensed and shipped by a licensed U.S. pharmacy. Subscription plans may be canceled at any time; your next refill date is shown in your account, and you must cancel by 11:59 p.m. Eastern Time the day before that date to avoid being billed for and receiving the next shipment. Once a refill is approved, dispensed, or shipped, it cannot be canceled or refunded. Individual results may vary.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality before they are dispensed. Compounded semaglutide and compounded tirzepatide are not generic versions of, and are not the same as, any brand-name medication.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro®, KwikPen®, and Foundayo™ are trademarks of Eli Lilly and Company. US Quick Health is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
Prescription required. Not available in West Virginia, Kansas, New Mexico, Louisiana or Mississippi.
Review Mounjaro pricing and prescription review details before requesting an evaluation. Prescribing depends on a clinical assessment.
A few simple steps to your medication
Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not generic versions of any brand-name medicine. Our guides explain whether compounded semaglutide is safe, how compounded tirzepatide differs from Zepbound and the GLP-1 compounding rules after the shortages. Use them to prepare questions for your provider.
Pricing depends on the medication prescribed and the plan you choose. Your cost will always include your provider consultation, prescription (if approved), and support from our care team. Medication prices vary by brand and dosage. You’ll see the exact price before starting treatment.
No, insurance is not required. We offer transparent, cash-pay pricing so you know upfront what your treatment will cost.
Our licensed providers may prescribe FDA-approved medications for weight management, including:
Providers may also prescribe medications that are FDA-approved for type 2 diabetes (such as Ozempic® or Mounjaro®) off-label for weight loss, when medically appropriate. Prescription decisions are always based on your health profile and provider judgment.
Treatment is generally available to adults with a BMI ≥30, or a BMI ≥27 with weight-related conditions such as high blood pressure, diabetes, or high cholesterol. A licensed provider will review your medical history and determine if treatment is appropriate for you.
In clinical trials, adults taking semaglutide 2.4 mg alongside diet and exercise lost an average of 14.9% of body weight over 68 weeks (STEP 1, New England Journal of Medicine, 2021), and adults taking tirzepatide 15 mg lost an average of 20.9% over 72 weeks (SURMOUNT-1, New England Journal of Medicine, 2022). Those are trial averages, not a promise: individual results vary, some people lose noticeably less, and a provider decides whether treatment is appropriate for you at all.
The most common side effects include nausea, diarrhea, constipation, and vomiting. Most are mild and improve over time. Your provider will review your health history and current medications, weigh the risks for your situation, and will not prescribe if treatment is not appropriate for you.
After your online consultation and provider approval, your prescription is filled by a licensed U.S. pharmacy. It ships in discreet packaging with tracking, and medications that need refrigeration ship in temperature-controlled packaging. Delivery time depends on your location and on the pharmacy that fills the prescription.
Yes. Your information is encrypted and stored securely. We follow strict HIPAA-compliant standards to protect your privacy and health data.
Yes. You’ll have access to our care team throughout your treatment. Providers can adjust your dosage, answer questions, and ensure your plan is working for you.
Medically reviewed by
Clinical Expertise: Anesthesiology, Emergency Medicine, Urology, and Oncology
Dr. Igde reviewed the medical information on this page for accuracy against current medical knowledge. This is an editorial, non-clinical review: it is not medical advice and does not create a doctor-patient relationship. Whether a treatment is appropriate for you is decided by an independent U.S. licensed provider.
For more information about the scope of the reviewed content and the role of our medical advisors, please visit our Medical Board page.
